Testing a noninvasive scan for serious lung mold infections in kids
Part of Infections, Lungs & breathing clinical trials.
This study uses noninvasive breathing/relates imaging (MRI or CT) to help diagnose mold infections in the lungs in children and young adults. It may help doctors find these infections sooner, especially in people with weakened immune systems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between about 4 months and under 22 years
- You have a higher risk condition, such as a blood/immune disorder, cancer, bone marrow failure, or a recent stem cell transplant
- You have new chest imaging changes in the last 4 days that fit specific mold-infection patterns
- You also have one of these: long low white blood cell counts for at least 5 days, treatment for graft-versus-host disease, or a known neutrophil/immune function problem
- A parent/guardian can consent (and your child can agree if appropriate)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging agent that may help doctors see mold infections in the body. It involves healthy volunteers and people with mold infections, and aims to improve how these infections are detected and monitored.
This study tracks how your immune system responds to serious mold infections, like aspergillosis or mucormycosis. It may help doctors understand why some infections are hard to treat and could lead to better care.
This study aims to detect invasive lung aspergillosis earlier by testing samples from your lungs and measuring specific lab markers. It may help doctors start the right antifungal treatment sooner when the infection is suspected.
This trial checks whether a PET-CT scan using a small amount of tracer (FDG) can help doctors better identify invasive fungal infections inside the body. It may be useful for guiding diagnosis when standard information is unclear.
This study uses a blood test to find fungal lung infections in people with blood cancers or those who had a stem cell transplant. It may help doctors diagnose and treat infections faster.
This trial tests a new drug, Fosmanogepix, for treating serious mold infections that are hard to treat with current medicines. It may be an option for people with limited treatment choices.
Hear when a new Pulmonary Invasive Fungal Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.